Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Alpha2-adrenoceptor antagonists with neuroprotective effects

March 15, 1996

Astra antioxidants for hypoxia

March 15, 1996

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Hematopoietic research at Temple University

March 15, 1996

Sanofi claims CCK-A agonists for obesity

March 15, 1996

Glaxo Wellcome reports antitumor drugs

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.